3/12/2025

Chlorothiazide Sodium Injection

Products Affected - Description

- Chlorothiazide injection, American Regent, 500 mg, vial, 1 count, NDC 00517-1820-01
- Chlorothiazide injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0658-20
- Chlorothiazide injection, Sagent, 500 mg, vial, 1 count, NDC 25021-0305-20

Reason for the Shortage

- American Regent did not provide a reason for the shortage.
- Fresenius Kabi did not provide a reason for the shortage.
- Sagent did not provide a reason for the shortage.

Available Products

- There is insufficient supply for usual ordering

Estimated Resupply Dates

- American Regent has chlorothiazide 500 mg vials in limited supply with weekly releases.
- Fresenius Kabi has chlorothiazide 500 mg vials on back order and the company estimates a release date of early-May 2025.
- Sagent has chlorothiazide 500 mg vials available on a limited allocation.

Updated

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.